Instituto Politécnico Nacional Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2013
NCT02049411
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Instituto Politecnico Nacional | National Polytechnic Institute